Status:
COMPLETED
Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults
Lead Sponsor:
Novartis
Collaborating Sponsors:
Novartis Vaccines
Conditions:
Encephalitis, Tick-Borne
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study it is to evalutate the persistence of antibodies after a booster immunisation with a TBE vaccine for adults
Eligibility Criteria
Inclusion
- Healthy volunteers of both sexes aged \>18 who participated in another study on TBE vaccination
Exclusion
- Subjects with any condition, in the opinion of the Investigator, might interfere with the evaluation of the study objectives.
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
179 Patients enrolled
Trial Details
Trial ID
NCT00311493
Start Date
February 1 2006
Last Update
March 13 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Regensburg, Germany